ArticleLeukemia research2013

Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).

Eyal C Attar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.